[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4663 Introduced in House (IH)]







109th CONGRESS
  2d Session
                                H. R. 4663

 To authorize the Secretary of Health and Human Services to reimburse 
   States for expenditures associated with the implementation of the 
   Medicare prescription drug benefit for dual eligible individuals.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            January 31, 2006

 Mr. Bradley of New Hampshire introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To authorize the Secretary of Health and Human Services to reimburse 
   States for expenditures associated with the implementation of the 
   Medicare prescription drug benefit for dual eligible individuals.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. AUTHORIZATION OF STATE REIMBURSEMENT FOR EXPENDITURES 
              ASSOCIATED WITH THE IMPLEMENTATION OF THE MEDICARE 
              PRESCRIPTION DRUG BENEFIT FOR DUAL ELIGIBLE INDIVIDUALS.

    (a) In General.--Notwithstanding section 1935(d) of the Social 
Security Act (42 U.S.C. 1396u-5(d)) or any other provision of law, with 
respect to covered part D drugs (as defined in section 1860D-2(e) of 
such Act (42 U.S.C. 1395w-102(e)) for full-benefit dual eligible 
individuals (as defined in section 1935(c)(6) of such Act (42 U.S.C. 
1396u-5(c)(6)) who are enrolled in a prescription drug plan under part 
D of title XVIII of such Act (or an MA-PD plan under part C of such 
title), the Secretary of Health and Human Services is authorized to 
fully reimburse a State (as defined for purposes of title XIX of such 
Act) for the costs described in subsection (b).
    (b) Costs Described.--For purposes of subsection (a), costs 
described in this subsection are costs incurred by the State as a 
result of the implementation of any program, with respect to access to 
covered part D drugs for individuals described in subsection (a), that 
is consistent with the guidance to States issued by the Centers of 
Medicare & Medicaid on January 14, 2006, titled ``Transitional State--
Part D Plan Coordination of Benefits'', without regard to the date of 
implementation of the program or the duration of the program. Such 
costs include copayments made on behalf of such individuals, 
administrative costs, and costs associated with disputed claim 
reconciliation.
                                 <all>